Cargando…
Development and characterization of novel erythropoiesis stimulating protein (NESP)
Studies on human erythropoietin (EPO) demonstrated that there is a direct relationship between the sialic acid-containing carbohydrate content of the molecule and its serum half-life and in vivo biological activity, but an inverse relationship with its receptor-binding affinity. These observations l...
Autores principales: | Egrie, J C, Browne, J K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363897/ https://www.ncbi.nlm.nih.gov/pubmed/11308268 http://dx.doi.org/10.1054/bjoc.2001.1746 |
Ejemplares similares
-
Pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in cancer patients: preliminary report
por: Heatherington, A C, et al.
Publicado: (2001) -
Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer
por: Smith, R E, et al.
Publicado: (2001) -
A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy
por: Glaspy, J, et al.
Publicado: (2001) -
Comparison of Pharmacokinetic, Pharmacodynamic and Tolerability Profiles of CKD-11101, Darbepoetin Alfa (NESP(®)) Biosimilar, to Those of NESP(®) After a Single Subcutaneous or Intravenous Administration to Healthy Subjects
por: Jeon, Inseung, et al.
Publicado: (2021) -
Very small deletions within the NESP55 gene in pseudohypoparathyroidism type 1b
por: Rezwan, Faisal I, et al.
Publicado: (2015)